CSL Ltd
ASX:CSL
CSL Ltd
Common Shares Outstanding
CSL Ltd
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CSL Ltd
ASX:CSL
|
Common Shares Outstanding
$483.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Immutep Ltd
ASX:IMM
|
Common Shares Outstanding
AU$1.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
29%
|
CAGR 10-Years
25%
|
|
Mesoblast Ltd
ASX:MSB
|
Common Shares Outstanding
$1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Common Shares Outstanding
AU$50.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Common Shares Outstanding
AU$323.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Common Shares Outstanding
AU$3.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
See Also
What is CSL Ltd's Common Shares Outstanding?
Common Shares Outstanding
483.1m
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's Common Shares Outstanding amounts to 483.1m USD.
What is CSL Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
0%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for CSL Ltd have been 2% over the past three years , 1% over the past five years .